Kazakhstan plans to launch production of 494 varieties of medicines through eight major investment projects, with total investment of 391.3 billion tenge. Health Minister Akmaral Alnazarova announced the plans at a government meeting.
The projects are expected to expand domestic medicine production and create more than 1,200 jobs. Production will be introduced in stages: 300 varieties are planned for 2027–2030, followed by another 194 in 2031–2034.
According to the Ministry of Health, Kazakhstan’s pharmaceutical market reached 1 trillion 285 billion tenge in 2025, up 31% over two years. Domestic production grew by 37% over the same period.
